Pharmaxis

Specialist pharmaceutical company

Pharmaxis Ltd (ACN 082 811 630) is a specialist pharmaceutical company involved in the research, development and commercialization of therapeutic products for chronic respiratory disorders. Its product Aridol forthe assessment of asthma issold in key international markets. Its product Bronchitol for cystic fibrosis is recently launched in Europe and Australia and its development pipeline of productsincludes, Bronchitol for bronchiectasis, PXS64 forthe treatment of lung fibrosis, ASM8 for asthma and PXS4728 for fibrotic disease. Pharmaxisislisted on the Australian Securities Exchange (symbol PXS). The company’s head office and manufacturing facilities are located in Sydney.